Dimitri Gonzalez

Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure

Sofiane Mohamed, Guillaume Pénaranda, Dimitri Gonzalez et al. · AIDS · 2014 · 70 citations

Life Sciences, Molecular Medicine, Molecular Virology +16

Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Performance, Turnaround Time, and Cost

Ketema Tafess, Timothy Ting-Leung Ng, Hiu Yin Lao et al. · Clinical Chemistry · 2020 · 61 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Uncommon Mutations at Residue Positions Critical for Enfuvirtide (T-20) Resistance in Enfuvirtide-Naive Patients Infected With Subtype B and Non-B HIV-1 Strains

François Roman, Dimitri Gonzalez, Christine Lambert et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 53 citations

Life Sciences, Infectious Diseases, Microbiology +16

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing

Christian Pou, Marc Noguera-Julián, Susana Pérez-Álvarez et al. · Clinical Infectious Diseases · 2014 · 46 citations

Public Health, Molecular Medicine, Molecular Virology +13

Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory

Daniela Ram, Dena Leshkowitz, Dimitri Gonzalez et al. · Journal of Virological Methods · 2014 · 26 citations

Life Sciences, Biology, Infectious Diseases +13